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Abstract 
Background: Previous studies have shown that the minor alleles (C allele) for melanocortin 4 
receptor (MC4R) rs17782313, may be associated with incidence of obesity and the risk of 
cardiovascular diseases (CVDs). Moreover, inflammation caused by the diet has been shown 
to have, potentially, unfavorable effects on CVD risk. This study sought to investigate the 
interactions between the dietary inflammatory index (DII) and MC4R gene variants on markers 
of CVD. 
Methods: This comparative cross-sectional study was conducted on 266 Iranian women with 
overweight and obesity. A food frequency questionnaire (FFQ) with 147 items was used to 
assess dietary intakes. Individuals were categorized into three groups based on rs17782313 
genotypes. Participants were also divided into four groups based on DII score. 
Results: Higher quartiles of DII were associated with lower levels of high density lipoproteins 
(HDL) (p=0.01) and higher levels of triglycerides (TG) (p= 0.04). There was a significant 
difference between genotypes for insulin (p < 0.001), HOMA index (p < 0.001), total body 
mineral content (p= 0.03), and bone mineral content (BMC) (p= 0.04). Our findings also 
showed significant interactions between DII score and rs17782313 polymorphism on total 
cholesterol (p= 0.06), total body mineral content (p < 0.001), BMC (p <0.001), soft lean mass 
(SLM) (p= 0.06), fat free mass (FFM) (p= 0.03), skeletal muscle mass (SMM) (p= 0.03), and 
basal metabolic rate (BMR) (p= 0.03).  
Conclusion: Higher DII scores were associated with lower HDL levels and higher TG levels, 
respectively; whilst significant differences were observed between the genotypes of 
rs17782313 for insulin and HOMA index, total body mineral content, and BMC. These results 
highlight that dietary compositions, gene variants, and their interaction, should be considered 
in CVD risk assessment. 
 
Introduction 
In the preceding decade, CVDs have been responsible for, approximately, one out of every 
three deaths, worldwide [1]. In developing countries, the percentage of all deaths attributable 
to CVDs increased from 18% in 1990, to 25% in 2010 [2], whilst in Iran, the mortality rate has 
also been rising [3]. The economic and societal costs of treating CVD are, and will continue to 
be, significant, particularly in developing countries [4]. The risk factors of CVD are 
multifactorial, including blood pressure, lipid disorders, insulin resistance, and type 2 diabetes 
[5]. In addition, many of these risk factors are affected by genetic factors, lifestyle, and 
environmental factors [6].  
The MC4R gene, that is encoded for the melanocortin 4 receptor, was the most common genetic 
cause of human obesity [7]. Cardiovascular risk factors such as hypertension [8], type 2 
diabetes mellitus [9], and insulin resistance [10] were also associated with the risk allele C for 
MC4R rs17782313. Moreover, subjects carrying common polymorphisms in the MC4R gene 
to are more susceptible to obesity and inflammation [11, 12].  
Contemporary data suggests that synergistic interactions between genetic predispositions to 
dietary and environmental factors may play an important role in affecting inflammation and 
the pathogenesis of obesity and CVD [13]. In addition, the diet is considered to be one of the 
most important factors in the inflammation process. Pro-inflammatory biomarkers, such as C-
reactive protein (CRP), interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), or cell adhesion 
molecules, can be used to assess the effect of dietary intake on inflammatory status [14]. A 
novel tool, known as the DII, was developed in 2009 [15] and updated in 2014 [16], is a 
validated measure of the inflammatory potential of an individual's diet [17]. A lower DII score 
demonstrates a more anti-inflammatory diet, whilst a higher DII score represents a more pro-
inflammatory diet [14]. 
 
The majority of recent observational studies have shown that DII is associated with the risk of 
CVD [14, 18-22]. In addition, some previous studies reported that cardiovascular risk factors 
were associated with the risk allele C for MC4R rs17782313 [23]. However, to our knowledge, 
no study has been conducted to investigate the interaction between the DII and MC4R gene 
variants on markers of CVD. 
Methods: 
Study population 
This cross-sectional study was conducted in 266 adult women who were referred to health 
centers in Tehran, Iran. In addition, only participants who had self-certified, good general 
health were included in the study. The age of subjects ranged between 18 and 56 years, with 
an average of 36.52 years (±8.32 years), and their body mass index ranged between 25  45 
kg/m2. Anthropometric measurements and blood samples were measured in the school of 
Nutritional Sciences and Dietetics at Tehran University of medical sciences. Ethical approval, 
and associated number IR.TUMS.VCR.REC.1395.1597, was obtained from the Ethics 
Commission of the Tehran University of Medical Sciences. Before commencing in this study, 
each participant signed a written informed consent form. The exclusion criteria were; history 
of hypertension, CVD, diabetes mellitus, or impaired liver renal function, regular use of 
medicine, including an oral contraceptive pill, smoking, excess intake of alcohol, pregnancy, 
currently lactating, and menopause. We also excluded participants if chronic disease affected 
their diet, were following an arbitrary special dietary regimen, or had weight fluctuations in the 
past 1 year.  
Assessment of DII  
A semi-quantitative, standard food frequency questionnaire (FFQ) was used to assess dietary 
intakes, which was previously validated in Tehran and adapted for this population [24]. The 
FFQ included 147 of foods commonly consumed by Iranians, which were defined by standard 
 
serving sizes for each food item. FFQ was collected through face-to-face interviews by trained 
interviewers at the health centers in Tehran. The software program, Nutritionist IV, was used 
for nutrient analysis, and was modified for Iranian foods [25]. We calculated the DII by using 
the method introduced by Shivappa et al [26]. The 29 food items that were used in the present 
study were as follows: energy, carbohydrate, protein, fat, dietary fiber, n-6 fatty acids, n-3 fatty 
acids, mono-unsaturated fatty acids, poly-unsaturated fatty acids, trans fatty acids, saturated 
fatty acids, cholesterol,  thiamin, riboflavin, niacin, Vitamin B-6, folate, vitamin B-12, vitamin 
A, β-carotene, Vitamin D, vitamin C, vitamin E, zinc, magnesium, selenium, iron, and onion, 
garlic. 
DNA Extraction and Sequencing of the Gene 
The MC4R gene primer was selected based on a previous study [27]. According to the 
manufacturer’s protocol, we extracted genomic DNA from blood samples with the use of the 
Mini Columns, Type G kit (GeneALL, Exgene). In addition, with the use of a Nano Drop 
spectrophotometer (Thermo Scientific Company, USA), we measured the concentration and 
purity of extracted DNA. We stored the extracted DNA at 4ºC, before sequencing was 
performed. The polymerase chain reaction (PCR) was performed using the following primers: 
forward primer 5-AAGTTCTACCTACCATGTTCTTGG-3 and reverse primer 5-
TTCCCCCTGAAGCTTTTCTTGTCATTTTGAT-3. PCR reactions were performed in a final 
volume of 20 μl, containing 1 μl extracted DNA, 0.5 μl primers F, 0.5 μl primers R, 10 μl 
Permix (Amplicon, Germany), and 8 μl Distilled water, with the following conditions in a DNA 
thermocycler: 1- primary denaturation at 95°C for 2 min; 2- Thirty- five cycles of denaturation 
at 95°C for 30 seconds, annealing at 58°C for 30 seconds, extension at 72°C for 30 seconds; 3- 
final extension at 72°C for 5 min; 4- final step at 4°C. Amplified DNA (7 μl) was digested with 
0.5 μl of BCII restriction enzyme (Fermentase, Germany) at 56 °C overnight. All products were 
 
visualized by agarose gel electrophoresis. Then, fragments containing three genotypes were 
distinguished: CC, CT, and TT. 
Assessment of Laboratory tests 
Fasting serum glucose, insulin, total cholesterol, triglyceride, low density lipoprotein (LDL), 
HDL were measured from blood samples drawn after 8–12 hours of overnight fasting. All 
participants were assessed by standard methods at the Nutrition and Biochemistry Laboratory 
of the school of Nutritional and Dietetics at Tehran University of medical sciences. 
Assessment of other variables  
Physical activity level was assessed by a validated questionnaire (International Physical 
Activity Questionnaire-Short Form) that included all domains of physical activity 
(Occupational, Transport, Yard/Garden, Household, and Leisure) and sitting. Body 
composition was measured using a multi-frequency bioelectrical impedance analyzer, InBody 
770 scanner (Inbody Co., Seoul, Korea), which records weight, body mass index (BMI), Body 
Fat Mass, body fat percentage, Fat-free Mass, visceral fat and waist to hip ratio. According to 
the manufacturer’s instructions, first, participants removed their shoes, coats, and sweaters, 
then they stood on the balance scale barefooted, and held the handles of the machines. Also, 
height was measured using a calibrated height gauge, with a precision of 0.5 cm (in the standing 
position, unshod, to the nearest 0.01 m). Obesity and overweight were defined as BMI 30 
kg/m2 and 25 BMI 29.9 kg/m2, respectively. 
Statistical analysis 
Data were analyzed using IBM SPSS version 22.0 (SPSS, Chicago, IL, USA). P <0.05 was 
considered statistically significant, but for interactions, P < 0.1 was considered significant. 
Comparison of quantitative variables between quartiles of DII or genotypes was performed 
using one-way analysis of variance (ANOVA) and analysis of covariance (ANCOVA). The 
interaction between DII category and genotypes on quantitative variables was assessed using 
 
generalized linear model (GLM) analysis. Analyses were conducted unadjusted and adjusted 
for BMI, age, energy intake and physical activity, 
Result 
Study population characteristics 
This comparative cross-sectional study was conducted on 266 women classified as overweight 
or obese. The means and standard deviation (SD) of age, weight, and BMI of individuals were 
36.52±8.32 years, 78.75±11.51 kg, and 30.33±3.65 kg/m2, respectively (Table 1). The 
frequencies of T and C alleles of rs17782313 were 42.5% and 57.5% respectively. The overall 
prevalence of rs17782313 genotypes was 30.1%, 24.8% and 45.1% for TT, TC and CC 
respectively. 
Association between biochemical parameters, body composition and DII 
All participants were divided into four groups, based on DII score. Before adjustment for 
confounding factors, significant differences between groups were found for HDL (p<0.001), 
as well as LDL (p=0.06) and TG (p=0.05) was near significant.  After adjustment for BMI, age, 
energy intake and physical activity, higher quartiles of DII were associated with lower levels 
of HDL (p=0.01) and higher levels of TG (p= 0.04) (Table 2). 
Association between biochemical parameters, body composition and rs17782313 genotypes 
A total of 266 Iranian women were categorized based on rs17782313 genotypes, and divided 
into three groups: TT genotype (n = 80), TC genotype (n = 66) and CC genotype (n = 120) 
(Table 3). After genotype categorization, we found significant differences between genotypes 
for insulin (p= 0.04), HOMA index (p= 0.01), total body mineral content (p= 0.03) and  a 
borderline significant difference for BMC (p= 0.05). Also, after adjustment for confounding 
factors (BMI, age, energy intake and physical activity), insulin (p < 0.001), HOMA index (p < 
0.001), total body mineral content (p= 0.03), and BMC (p= 0.04) maintained their significant 
differences (Table 3). 
 
Interaction between DII and MC4R gene variants on markers of CVD 
Using the GLM, the interaction between MC4R polymorphism (rs17782313) and DII score 
(quartiles) on CVD was examined. We found a significant relationship between TC genotype 
and LDL (p <001), total cholesterol (p= 0.04), and insulin (p= 0.04). Moreover, we observed a 
significant association between CC genotype and total cholesterol (p=0.03). Significant 
interactions were observed between DII score and rs17782313 SNP in terms of total body 
mineral content (p <0.001), BMC (p <0.001), SLM (p= 0.06), FFM (p= 0.03), SMM (p= 0.03), 
and basal metabolic rate (BMR) (p= 0.03), such that all variables decreased for individuals 
with the CC genotype, whilst all variables were increased for those carrying the TC and TT 
genotypes (Figure 1). In addition, a significant interaction was observed between DII score and 
rs17782313 genotypes on level of total cholesterol (p= 0.06) (Table 4). 
Discussion 
This cross-sectional study investigated the interaction between the DII and MC4R gene 
variants on markers of CVD in overweight and obese women. Our results showed that higher 
DII scores were associated with lower HDL levels and higher level of TG. This result agrees 
with some previous studies that reported the DII score were related with lipid profile [28]. Also, 
significant differences were observed between the genotypes of rs17782313 for insulin and 
HOMA index, total body mineral content, and BMC. Concordantly, some previous studies 
reported that individuals with the CC genotype were more susceptible to type 2 diabetes [29]. 
Furthermore, the main finding and novelty of our study is that there was a significant 
interaction between DII score and rs17782313 polymorphism on cholesterol, total body 
mineral content, BMC, SLM, FFM, SMM, and BMR. 
Previous studies in this field have focused on investigating the association between DII score 
and chronic diseases, such as CVD, diabetes, obesity, and bone fracture risk [30-32]. However, 
 
the interplay between diet and genes is scarcely considered, thus, we evaluated the interaction 
between the DII and MC4R rs17782313 polymorphism on CVD markers. Although several 
studies have assessed the interaction of MC4R and diet, such as metabolic syndrome, diabetes, 
and obesity [29, 33], no investigation has been conducted to assess the interaction between DII 
and MC4R rs17782313 polymorphism. We found that the association between the MC4R 
rs17782313 polymorphism and total cholesterol, BMR, and some body composition 
parameters (total body mineral content, BMC, SLM, FFM, and SMM), is dependent on the DII 
score of the individuals dietary pattern. Thus, the highest quartile of the DII, compared to the 
lowest, showed reductions in total body mineral content, BMC, BMR, FFM, SMM, and SLM 
for women with the CC genotype, but increases for those carrying the TT and TC genotypes. 
Also, higher DII scores were associated with higher levels of total cholesterol in individuals 
with the TT, TC, and CC genotypes, although the increase in the CC genotype was greater than 
the TC and TT genotypes. A previous study investigated the impact of the Malmö Diet on the 
association between the MC4R rs17782313 and body composition parameters, in Southern 
Sweden women and men, but found no significant interaction. The limitation of the Rukh et al 
[33] study was that, although the authors examined the interaction between MC4R with total 
energy intake, fiber, and macronutrients, dietary patterns or other dietary factors were not 
considered. Also, another study demonstrated that the relationship between the MC4R-
rs17782313 polymorphisms and type 2 diabetes depends on the diet, however, no significant 
interaction between MC4R-rs17782313 polymorphisms and folate intake on FBS was observed 
[29], and the effect of other parameters of body composition (FM, FFM, BMR, and SMM) and 
lipid profiles (total cholesterol, TG, LDL, HDL) have not been examined in this study. 
In line with our findings, the majority of previous studies have reported that the mean total 
cholesterol levels were higher, albeit non-significantly, in the CC genotype, as compared to 
other genotypes t [34, 35]. However, a prospective study showed that a MC4R (rs17782313) 
 
variant is likely to have an effect on the level of total cholesterol [23]. It is conceivable that the 
interaction between DII and MC4R polymorphism can explain the findings. Indeed, is not 
surprising that adherence to a pro-inflammatory diet could exacerbate the genetic susceptibility 
to dyslipidemia of high total cholesterol in MC4R risk allele carriers. The MC4R melanocortin 
4receptor is the most common genetic cause of human obesity; indeed, it has been reported that 
melanocortinergic pathways, involving MC4R-regulated neurons, seem to possess an 
important role in regulating metabolic and behavioral responses to food intake [36]. Moreover, 
up-regulation of the mRNAs for MC4R, along with IL-6 in the hypothalamic arcuate, directly 
promote lipid uptake and fat accumulation in white adipose tissue [37]. To some extent, this 
evidence can explain the significant interaction we found in the Iranian female population 
between the variant at MC4R and inflammation (caused by food) on plasma lipid 
concentrations. However, polymorphism rs17782313 is located 188 kb downstream of the 
MC4R gene, and is not likely to be the causal variant. 
It has been reported that fat-free mass makes a larger contribution to bone mineral density early 
in the life course, while fat mass plays a more prominent role in bone mineral density in the 
later stages of life [37-39]. We observed an inverse association of the rs17782313 C risk allele 
with BMC and total body mineral content. It is conceivable that this is due to the, relatively, 
lower fat-free mass in MC4R risk allele carriers. We also found that adherence to a pro-
inflammatory diet was associated with a reduction of BMC, FFM, SLM, SMM, BMR and total 
body mineral content in MC4R risk allele carriers. Indeed, it has been reported that leptin, 
independent of the fat mass, is a potent inhibitor of bone formation acting through the central 
nervous system [40]. Some previous studies have reported that children with MC4R deficiency 
have increased growth hormone, BMC, and bone mineral density, although a concomitant 
increase in lean mass has not been reported [41, 42]. On the other hand, a positive association 
between DII and plasma leptin concentration has been reported [43], and it has been observed 
 
that cytokines and biomarkers of inflammation were associated with reduced growth hormone 
production [44, 45]. Although it may be a viable mechanism to, at least in part, explain our 
results, it is unlikely to be the sole mechanism, and thus, we strongly recommend that more 
investigation be undertaken in this regard. 
Although we present novel findings regarding the interaction between the dietary inflammatory 
index and MC4R gene variants on cardiovascular risk factors, there are some limitations that 
must be considered. One limitation is that we did not dichotomize women into postmenopausal 
and premenopausal, or, overweight and obese [46]. Although we controlled for several 
potential confounders, the effects of remaining confounders cannot be ignored, and must be 
considered in any future research. Our study population was women, classified as being 
overweight or obese, so our results may not be extended to other populations for example 
children or the elderly. Therefore, further work in specific populations is a pragmatic avenue 
for further research. 
Conclusion 
Higher DII scores were associated with lower HDL levels and higher TG levels, respectively; 
whilst significant differences were observed between the genotypes of rs17782313 for insulin 
and HOMA index, total body mineral content, and BMC. These results highlight that dietary 
compositions, gene variants, and their interaction, should be considered in CVD risk 
assessment. 
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